Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05203302
Other study ID # 18-00437
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 12, 2018
Est. completion date January 1, 2025

Study information

Verified date October 2023
Source NYU Langone Health
Contact David M Landsberger, MD
Phone 212-263-8455
Email david.landsberger@nyulangone.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to understand performance with a cochlear implant. The long-term goals of this research are to improve sound perception with cochlear implants and to better understand the functioning of the auditory system. Information from individuals with and without cochlear implants will be compared.


Description:

The overall objectives of this research are to 1) gain a better understanding of fundamental psychophysical abilities with electrical stimulation as a function of age (child vs adult), age at onset of deafness (pre- vs post-lingual), and acoustic hearing (normal vs limited or residual); and 2) determine whether manipulations in CI coding strategies will improve psychophysical and speech recognition outcomes for early implanted children. This work is expected to provide new insights into the corresponding improvements in perceptual outcomes to these newer strategies have been modest at best and performance has begun to level off.


Recruitment information / eligibility

Status Recruiting
Enrollment 190
Est. completion date January 1, 2025
Est. primary completion date January 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 80 Years
Eligibility Inclusion Criteria: - Be 7 years of age or older and pre-lingually implanted with a cochlear implant (before the age of 2 years), have aided residual hearing, or have normal hearing. - Be ages 18 or older and post-lingually implanted or have normal hearing. - Be ages 18-35 and pre-lingually implanted. Exclusion Criteria: - Any child implanted post-lingually

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Single-Electrode Pulse Train
AIM 2 - Stimuli will be presented on one of three electrodes (apical, middle, and basal) at an amplitude between 10 and 100% dynamic range in µAs in 10% dynamic range steps. Stimulation will be delivered at a rate of 1000 pps. The process will be repeated in random order until 20 loudness estimates are obtained for each stimulus (3 electrodes x 2 rates x 10 amplitudes) for each subject. The dynamic range will be determined by measuring the maximum acceptable loudness (MAL) and threshold for each of the stimuli. MAL will be measured by slowly raising the current level for each stimulus until the subject reports that it is as loud as they are willing to accept without becoming uncomfortably loud.
Modulation Detection Threshold (MDT) and Gap Detection Tasks
AIM 1 - MDT will be set at 150 Hz. Testing will be conducted in soundfield in a sound booth at 60 dB Sound Pressure Level (SPL) while the participant listens with both implants adjusted to user setting.
Sound coding strategy.
Aim3 - Spectral-temporally modulated ripple test (SMRT), Quick Spectral Modulation Detection (QSMD), Modulation Detection, Gap Detection. CNC words will be set in quiet and Az-Bio/BabyBio sentences in quiet and multi-talker babble (+10 and +5 dB SNR) using both the subject's clinical map and the new reduced channels map. Tests will be presented in the soundfield at 60 dB SPL
Electric-only spectral resolution
Aim 1- Spectral resolution will be tested using frequency allocations consisting of the full default clinical range as well as the subject's clinical frequency allocation if they differ. For Hybrid electrode users in which electrode contacts are closer in proximity in the cochlea, maps with a frequency allocation of 938-7938 Hz will also be tested in that it will closely approximate the frequency spacing of a Nucleus Contour Advance electrode array. Spectral resolution will be measured with three repetitions of the SMRT and one repetition of the QSMD test. Testing will be presented at 60 dB SPL in the soundfield with the acoustic ear plugged and muffed.

Locations

Country Name City State
United States NYU Langone Health New York New York

Sponsors (1)

Lead Sponsor Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in loudness growth in Cochlear Implant participants Power functions will be fit for each of the loudness growth curves. Data will be analyzed using a mixed-design ANOVA with the two groups as the between-subjects factor and electrode and rate as within-subject factors. Baseline Visit (Day 1) , Visit week 10
Primary Change in temporal resolution in Cochlear implant participants A mixed-effect ANOVA will be conducted to determine if there is an effect of age group (children vs adults) and hearing condition (CI vs NH) for both modulation detection and gap detection tasks. Post-hoc two-sample t-tests will compare differences between NH and CI children as well as NH and CI adults. Post-hoc paired t-tests will compare differences between adults and children for both the NH and the CI populations. Baseline Visit (Day 1) , Visit week 10
Primary Change in spectral resolution in Cochlear implant participants A one-way ANOVA will be used to calculate the differences between the four groups. If significant, post-hoc t-tests will be performed using Rom's modified Bonferroni Type I error correction. Baseline Visit (Day 1) , Visit week 10
Primary Difference in performance between the reduced channel map and the full map A mixed-design ANOVA will be conducted for each of the tests with subject population as the between-subjects factor and sound coding strategy as the within-subjects factor Baseline Visit (Day 1) , Visit week 10
See also
  Status Clinical Trial Phase
Completed NCT05086809 - Investigation of an Updated Bone-anchored Sound Processor N/A
Withdrawn NCT02890576 - Ambulatory Telemonitoring of People With Hearing Loss and Having a Cochlear Implant COCHLESURV
Completed NCT01256229 - Outcomes In Children With Developmental Delay And Deafness Phase 1
Recruiting NCT04795986 - First Clinical Evaluation of HEARO Robotic Cochlear Implantation Surgery in Austria
Recruiting NCT05867173 - Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces N/A
Completed NCT06104813 - Evaluation of Deaf Men's Knowledge About Sexual Health
Completed NCT04563884 - Validity of the French Version of Deafness Questionnaires for Children and Adolescents
Not yet recruiting NCT06088953 - EARLY DETECTION OF DEAFNESS IN A MEMORY CENTER N/A
Completed NCT03980808 - American Sign Language-Accessible Diabetes Education N/A
Completed NCT03694340 - Optimization of Cochlear Implant MAP-parameters in Children N/A
Terminated NCT01959152 - Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus™ Mid-Scala Electrode N/A
Completed NCT02539901 - Development of a Deaf Child With a Cochlear Implant. N/A
Completed NCT00511381 - Genetic Testing in Detection of Late-Onset Hearing Loss N/A
Withdrawn NCT00604474 - Development of Auditory Skills in Young Deaf Children With Bilateral Cochlear Implants N/A
Terminated NCT03867058 - Tradeoff Between Spatial and Temporal Resolution
Completed NCT01109576 - Workshops for Veterans With Vision and Hearing Loss Phase 0
Completed NCT01400178 - Cochlear Implants in Post-lingually Children: Results After 10 Years N/A
Completed NCT04106063 - A New Speech, Spatial, and Qualities of Hearing Scale Short-Form for Deaf Children
Active, not recruiting NCT03352154 - Long Latency Auditory Evoked Potentials (P300) Outcomes in Patients With Unilateral Cochlear Implants N/A
Recruiting NCT04495660 - Restauration of the Auditory and Cognitive Functions in Cochlear Implanted Deaf Children in fNIRS N/A